Annals of Neurology · 2000 · 258 citations · 25 references
Life SciencesNeurologyNeuroscienceClinical NeuroscienceNeural EngineeringNeurodegenerationDeep Brain StimulationNeurodegenerative DiseasesNeuromodulationNeurostimulationParkinson DiseaseParkinsonian DisordersDeep Brain Stimulation ComplicationsDeep Brain Stimulation EffectsDeep Brain Stimulation PhysiologyParkinson’s Disease TreatmentTissue Damage Mechanisms
We report on the pathological findings in the brains of 8 Parkinson's disease patients treated with deep brain stimulation (DBS) of the thalamic ventral intermediate nucleus (6 cases) and subthalamic nucleus (2 cases). DBS was performed continuously for up to 70 months. All brains showed well-preserved neural parenchyma and only mild gliosis around the lead track compatible with reactive changes due to surgical placement of the electrode. We conclude that chronic DBS does not cause damage to adjacent brain tissue.
25
A new variant of Creutzfeldt-Jakob disease in the UK
Robert Will, James W. Ironside, Martin Zeidler et al. · The Lancet · 1996 · 2.7K citations
Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent
M. E. Bruce, Robert Will, James W. Ironside et al. · Nature · 1997 · 2K citations
Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD
John Collinge, Katie Sidle, Julie Meads et al. · Nature · 1996 · 1.7K citations